Title : Transcriptomics reveal different metabolic strategies for acid resistance and gamma-aminobutyric acid (GABA) production in select Levilactobacillus brevis strains.

Pub. Date : 2021 Sep 6

PMID : 34488774






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Levilactobacillus brevis Lbr-6108 (Lbr-6108), formerly known as L. brevis DPC 6108, and Levilactobacillus brevis Lbr-35 (Lbr-35) had similar growth profiles but differed significantly in GABA secretion and acid resistance. gamma-Aminobutyric Acid lamin B receptor Homo sapiens
2 Levilactobacillus brevis Lbr-6108 (Lbr-6108), formerly known as L. brevis DPC 6108, and Levilactobacillus brevis Lbr-35 (Lbr-35) had similar growth profiles but differed significantly in GABA secretion and acid resistance. gamma-Aminobutyric Acid lamin B receptor Homo sapiens
3 Lbr-6108 produced GABA early within the growth phase and produced significantly more GABA than Lbr-35 and the type strain Levilactobacillus brevis ATCC 14869 after the stationary phase. gamma-Aminobutyric Acid lamin B receptor Homo sapiens
4 Lbr-6108 produced GABA early within the growth phase and produced significantly more GABA than Lbr-35 and the type strain Levilactobacillus brevis ATCC 14869 after the stationary phase. gamma-Aminobutyric Acid lamin B receptor Homo sapiens
5 The GAD operon, responsible for GABA production and secretion, activated in Lbr-6108 after only 6 h of fermentation and continued throughout the stationary phase. gamma-Aminobutyric Acid lamin B receptor Homo sapiens
6 Furthermore, the increased and rapid GABA production of Lbr-6108 highlights the strain"s potential as a therapeutic and the overall value of screening microbes for effector molecule output. gamma-Aminobutyric Acid lamin B receptor Homo sapiens